UTAH MEDICAL PRODUCTS, INC. CONSOLIDATED STATEMENT OF INCOME - USD ($) shares in Thousands, $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Details
Sales, net	$ 12,955	$ 12,572	$ 38,707	$ 36,140
Cost of goods sold	4,769	4,499	14,838	13,336
Gross profit	8,186	8,073	23,869	22,804
Operating expense
Selling, general and administrative	2,933	2,848	8,779	8,669
Research & development	112	127	370	385
Total operating expenses	3,045	2,975	9,149	9,054
Operating income	5,141	5,098	14,720	13,750
Other income	198	59	348	130
Income before provision for income taxes	5,339	5,157	15,068	13,880
Provision for income taxes	1,059	951	3,150	3,224
Net income	$ 4,280	$ 4,206	$ 11,918	$ 10,656
Earnings per common share (basic)	$ 1.18	$ 1.15	$ 3.27	$ 2.92
Earnings per common share (diluted)	$ 1.18	$ 1.15	$ 3.26	$ 2.91
Shares outstanding - basic	3,625	3,647	3,641	3,645
Shares outstanding - diluted	3,634	3,658	3,650	3,656
Other comprehensive income (loss)
Foreign currency translation net of taxes of $0 in all periods	$ (2,572)	$ (782)	$ (5,377)	$ (787)
Total comprehensive income	$ 1,708	$ 3,424	$ 6,541	$ 9,869